|
Jul 1
|
Adaptive Biotechnologies and Flatiron Health Announce Integration of clonoSEQ® MRD Testing into OncoEMR®
|
|
Jun 26
|
Adaptive Biotechnologies (ADPT) Surges 12.5%: Is This an Indication of Further Gains?
|
|
Jun 25
|
Craig-Hallum Initiates Coverage of Adaptive Biotechnologies (ADPT) stock, Gives Buy
|
|
Jun 25
|
Is Bio-Techne Stock Underperforming the Nasdaq?
|
|
Jun 13
|
What Makes Adaptive Biotechnologies (ADPT) a New Buy Stock
|
|
May 26
|
Is Adaptive Biotechnologies (ADPT) Outperforming Other Medical Stocks This Year?
|
|
Mar 11
|
Adaptive Biotechnologies Launches Assay Enhancements to Increase clonoSEQ® Sensitivity for Clinical MRD Detection in Diffuse Large B-Cell Lymphoma
|
|
Jan 17
|
Is Adaptive Biotechnologies (ADPT) Stock Outpacing Its Medical Peers This Year?
|
|
Jan 16
|
Adaptive Biotechnologies (ADPT) Soars 18.0%: Is Further Upside Left in the Stock?
|
|
Jan 2
|
Adaptive Biotechnologies to Present at the 43rd Annual J.P. Morgan Healthcare Conference
|
|
Jan 1
|
Is ANI Pharmaceuticals (ANIP) Outperforming Other Medical Stocks This Year?
|
|
Nov 1
|
November 2024's Top US Penny Stocks With Growth Potential
|
|
Aug 29
|
Adaptive Announces IVDR Certification for clonoSEQ® in European Union
|
|
Jul 29
|
Strong week for Adaptive Biotechnologies (NASDAQ:ADPT) shareholders doesn't alleviate pain of three-year loss
|
|
May 31
|
Adaptive Biotechnologies Announces Data Supporting the Clinical Benefits of MRD Assessment with clonoSEQ® To Be Presented at the Upcoming 2024 ASCO Annual Meeting and EHA2024 Hybrid Congress
|
|
May 29
|
Adaptive Biotechnologies to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
|
|
May 9
|
Adaptive Biotechnologies First Quarter 2024 Earnings: Beats Expectations
|
|
May 8
|
Why Adaptive Biotechnologies Topped the Market Today
|
|
May 8
|
Adaptive Biotechnologies Corporation (NASDAQ:ADPT) Q1 2024 Earnings Call Transcript
|
|
May 8
|
Adaptive Biotechnologies Corp (ADPT) Q1 2024 Earnings Call Transcript Highlights: Strategic ...
|